Theratechnologies Ebit from 2010 to 2024
| THTX Stock | USD 1.20 0.01 0.83% |
EBIT | First Reported 1997-02-28 | Previous Quarter 6.5 M | Current Value 6.2 M | Quarterly Volatility 5.2 M |
Check Theratechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Theratechnologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.1 M, Total Revenue of 98.7 M or Gross Profit of 75 M, as well as many indicators such as Price To Sales Ratio of 0.56, Dividend Yield of 0.0 or Days Sales Outstanding of 62.42. Theratechnologies financial statements analysis is a perfect complement when working with Theratechnologies Valuation or Volatility modules.
Theratechnologies | Ebit |
Latest Theratechnologies' Ebit Growth Pattern
Below is the plot of the Ebit of Theratechnologies over the last few years. It is Theratechnologies' EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Theratechnologies' overall financial position and show how it may be relating to other accounts over time.
| Ebit | 10 Years Trend |
|
Ebit |
| Timeline |
Theratechnologies Ebit Regression Statistics
| Arithmetic Mean | (10,606,468) | |
| Coefficient Of Variation | (103.85) | |
| Mean Deviation | 7,837,747 | |
| Median | (7,676,128) | |
| Standard Deviation | 11,014,477 | |
| Sample Variance | 121.3T | |
| Range | 43M | |
| R-Value | (0.58) | |
| Mean Square Error | 87.2T | |
| R-Squared | 0.33 | |
| Significance | 0.02 | |
| Slope | (1,419,867) | |
| Total Sum of Squares | 1698.5T |
Theratechnologies Ebit History
Other Fundumenentals of Theratechnologies
About Theratechnologies Financial Statements
Theratechnologies investors use historical fundamental indicators, such as Theratechnologies' Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Theratechnologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EBIT | -12.3 M | -12.9 M | |
| EBITDA | -11.9 M | -12.5 M | |
| Ebt Per Ebit | 1.99 | 2.09 | |
| Ebit Per Revenue | (0.13) | (0.12) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Theratechnologies Stock Analysis
When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.